Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

Completed · Phase 2 · Has a placebo group

Conditions studied: Obesity, Obese, Overweight or Obesity

In brief

A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and women

Key facts

Study ID
NCT05616013
Run by
Eli Lilly and Company
People needed
507
Starts
2022-11-16
Expected to finish
2025-06-14
Last updated by the study team
2026-07-08

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.